ENTERO Q4 FY26 Concall Summary & Key Takeaways (ENTERO)

ENTERO Q4 FY26 (Mar-2026 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

  • ENTERO Financials
  • ENTERO Shareholding Pattern
  • ENTERO Earnings Documents
  • ENTERO Announcements
  • ENTERO Corporate Actions
  • ENTERO Bulk, Block & Insider Deals
  • ENTERO Delivery Data
  • ENTERO Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Entero Healthcare Solutions Ltd (ENTERO) Q4FY26 Concall Summary - Mar-2026 Qtr

Performance Overview

  • The company reported a strong performance for the quarter, with revenue growing by 42.6% year-over-year, driven by a combination of organic growth (17.1%) and contributions from new acquisitions (26%).
  • A key highlight was the significant expansion in profitability, with the EBITDA margin improving by 85 basis points year-over-year to 4.5%, and the gross margin expanding by 110 basis points to 10.9%. This was attributed to a better product mix and enhanced procurement efficiencies.
  • The company successfully integrated seven acquisitions made during the year, significantly scaling its presence in the MedTech space, which now contributes over INR 1,000 crore in annualized revenue.
  • Management emphasized a strong focus on operational efficiency, which led to an improvement in the working capital cycle, with networking capital days reducing to 59 from 64 in the previous quarter, and a robust operating cash flow of INR 104.6 crore for the quarter.
  • The company provided confident guidance for FY27, projecting a 23% consolidated revenue growth (excluding new acquisitions) and an EBITDA margin of 5%, signaling a continued focus on profitable growth and operational leverage.

Financial Metrics

Log in to Stocksigma to read the Financial Metrics section of this summary.

Operating Performance / Business Segments

Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.

Key Discussions & Insights

Log in to Stocksigma to read the Key Discussions & Insights section of this summary.

Outlook and Guidance

Log in to Stocksigma to read the Outlook and Guidance section of this summary.

Challenges / Concerns

Log in to Stocksigma to read the Challenges / Concerns section of this summary.

Industry / Competitive Landscape

Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.

Overall Summary

Log in to Stocksigma to read the Overall Summary section of this summary.

  • ENTERO Q4FY26 Concall Transcript
  • ENTERO Q4FY26 Management Mirror
  • ENTERO Q3FY26 Concall Summary (Dec-2025 Qtr)
  • ENTERO Q1FY27 Concall Summary (Jun-2026 Qtr)